Protagonist Therapeutics Inc (PTGX) — Financial Flexibility Index
Protagonist Therapeutics Inc (PTGX) has a Financial Flexibility Index of -0.03x as of September 2025. Free cash flow of $-1.85 Million (operating CF $-1.94 Million minus capex $88.00K) represents 0% of total liabilities ($56.25 Million). Check PTGX total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Protagonist Therapeutics Inc Financial Flexibility Index (2014–2024)
Historical Financial Flexibility Index trend for Protagonist Therapeutics Inc across 11 annual periods. For the full cash flow conversion analysis, see PTGX cash flow metrics.
Annual Financial Flexibility Index for Protagonist Therapeutics Inc (2014–2024)
Year-by-year free cash flow to debt coverage for Protagonist Therapeutics Inc. Explore PTGX operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.67x | $185.51 Million | $184.15 Million | $69.43 Million | ▲ +181.6% |
| 2023 | -3.27x | $-69.63 Million | $-70.24 Million | $21.27 Million | ▲ +1.5% |
| 2022 | -3.32x | $-107.34 Million | $-108.14 Million | $32.32 Million | ▼ -48.3% |
| 2021 | -2.24x | $-106.76 Million | $-107.86 Million | $47.67 Million | ▼ -39.5% |
| 2020 | -1.61x | $-72.01 Million | $-72.48 Million | $44.86 Million | ▼ -196.6% |
| 2019 | -0.54x | $-40.56 Million | $-41.53 Million | $74.95 Million | ▲ +70.5% |
| 2018 | -1.83x | $-49.46 Million | $-49.95 Million | $26.96 Million | ▼ -1842.7% |
| 2017 | 0.11x | $4.54 Million | $3.87 Million | $43.10 Million | ▲ +102.3% |
| 2016 | -4.60x | $-29.59 Million | $-29.97 Million | $6.43 Million | ▼ -72.6% |
| 2015 | -2.66x | $-13.99 Million | $-14.38 Million | $5.25 Million | ▲ +15.1% |
| 2014 | -3.14x | $-7.44 Million | $-7.74 Million | $2.37 Million | — |